Fontana RJ - Search Results

1

Hepatitis B e antigen loss in adults and children with chronic hepatitis B living in North America: A prospective cohort study.

Lee WM, King WC, Janssen HLA, Ghany MG, Fontana RJ, Fried M, Sterling RK, Feld JJ, Wang J, Mogul DB, Cooper SL, Bisceglie AMD; Hepatitis B Research Network (HBRN). Lee WM, et al. Among authors: fontana rj. J Viral Hepat. 2021 Nov;28(11):1526-1538. doi: 10.1111/jvh.13591. Epub 2021 Aug 11. J Viral Hepat. 2021. PMID: 34355475 Free PMC article.

2

Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B.

Fontana RJ, Keeffe EB, Carey W, Fried M, Reddy R, Kowdley KV, Soldevila-Pico C, McClure LA, Lok AS; National Institutes of Health Hepatitis B Virus Orthotopic Liver Transplantation Study Group. Fontana RJ, et al. Liver Transpl. 2002 May;8(5):433-9. doi: 10.1053/jlts.2002.32983. Liver Transpl. 2002. PMID: 12004342 Free article.

3

Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy.

Fontana RJ, Hann HW, Perrillo RP, Vierling JM, Wright T, Rakela J, Anschuetz G, Davis R, Gardner SD, Brown NA. Fontana RJ, et al. Gastroenterology. 2002 Sep;123(3):719-27. doi: 10.1053/gast.2002.35352. Gastroenterology. 2002. PMID: 12198698

4

NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States.

Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM, Lok AS. Marrero JA, et al. Among authors: fontana rj. Hepatology. 2002 Dec;36(6):1349-54. doi: 10.1053/jhep.2002.36939. Hepatology. 2002. PMID: 12447858 Free article.

5

Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients.

Marrero JA, Su GL, Wei W, Emick D, Conjeevaram HS, Fontana RJ, Lok AS. Marrero JA, et al. Among authors: fontana rj. Hepatology. 2003 May;37(5):1114-21. doi: 10.1053/jhep.2003.50195. Hepatology. 2003. PMID: 12717392

6

Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma.

Marrero JA, Fontana RJ, Fu S, Conjeevaram HS, Su GL, Lok AS. Marrero JA, et al. Among authors: fontana rj. J Hepatol. 2005 Feb;42(2):218-24. doi: 10.1016/j.jhep.2004.10.005. J Hepatol. 2005. PMID: 15664247

7

Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass.

Marrero JA, Hussain HK, Nghiem HV, Umar R, Fontana RJ, Lok AS. Marrero JA, et al. Among authors: fontana rj. Liver Transpl. 2005 Mar;11(3):281-9. doi: 10.1002/lt.20357. Liver Transpl. 2005. PMID: 15719410 Free article. Clinical Trial.

8

Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort.

Marrero JA, Fontana RJ, Barrat A, Askari F, Conjeevaram HS, Su GL, Lok AS. Marrero JA, et al. Among authors: fontana rj. Hepatology. 2005 Apr;41(4):707-16. doi: 10.1002/hep.20636. Hepatology. 2005. PMID: 15795889 Free article.

9

Acute liver failure due to amoxicillin and amoxicillin/clavulanate.

Fontana RJ, Shakil AO, Greenson JK, Boyd I, Lee WM. Fontana RJ, et al. Dig Dis Sci. 2005 Oct;50(10):1785-90. doi: 10.1007/s10620-005-2938-5. Dig Dis Sci. 2005. PMID: 16187174 Free article. Review.

10

Cognitive function in hepatitis C patients with advanced fibrosis enrolled in the HALT-C trial.

Fontana RJ, Bieliauskas LA, Back-Madruga C, Lindsay KL, Kronfol Z, Lok AS, Padmanabhan L; HALT-C Trial Group. Fontana RJ, et al. J Hepatol. 2005 Oct;43(4):614-22. doi: 10.1016/j.jhep.2005.04.006. J Hepatol. 2005. PMID: 16237784 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

394 results

Search Page